Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Other Non Operating Income: 2021-2022

Historic Other Non Operating Income for Cardiol Therapeutics (CRDL) over the last 2 years, with Sep 2022 value amounting to $2.3 million.

  • Cardiol Therapeutics' Other Non Operating Income rose 2201.10% to $2.3 million in Q3 2022 from the same period last year, while for Sep 2022 it was $4.0 million, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2021, which is 5969.96% up from last year.
  • Cardiol Therapeutics' Other Non Operating Income amounted to $2.3 million in Q3 2022, which was up 71.87% from $1.3 million recorded in Q2 2022.
  • In the past 5 years, Cardiol Therapeutics' Other Non Operating Income registered a high of $2.3 million during Q3 2022, and its lowest value of -$1.1 million during Q1 2022.
  • Moreover, its 2-year median value for Other Non Operating Income was $98,993 (2021), whereas its average is $572,172.
  • Examining YoY changes over the last 5 years, Cardiol Therapeutics' Other Non Operating Income showed a top increase of 2,201.10% in 2022 and a maximum decrease of 2,690.46% in 2022.
  • Over the past 2 years, Cardiol Therapeutics' Other Non Operating Income (Quarterly) stood at $1.5 million in 2021, then skyrocketed by 2,201.10% to $2.3 million in 2022.
  • Its Other Non Operating Income was $2.3 million in Q3 2022, compared to $1.3 million in Q2 2022 and -$1.1 million in Q1 2022.